Related Experiment Video
Updated: Nov 8, 2025

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
hsa‑miR‑5580‑3p inhibits oral cancer cell viability, proliferation and migration by suppressing LAMC2
1Department of Gastroenterology, Puai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430033, P.R. China.
Abstract:
The present study aimed to explore whether and how microRNA‑5580‑3p (miR‑5580‑3p) affected oral cancer (OC) cell phenotypes via regulation of laminin subunit γ2 (LAMC2). Bioinformatics analysis was used to identify miR‑5580‑3p/LAMC2, a novel interactome that, to the best of our knowledge, has not been studied previously in OC. In the present study, the expression levels of miR‑5580‑3p and LAMC2 were detected by reverse transcription‑quantitative PCR, while the protein expression levels of LAMC2 were identified using western blotting. To determine the effects of miR‑5580‑3p and LAMC2 in OC, a number of experiments, including Cell Counting Kit‑8, 5‑bromo‑2'‑deoxyuridine cell proliferation and wound healing migration assays, were performed using OC SCC‑4 and Cal‑27 cell lines. Additionally, luciferase reporter assays were employed to examine the interaction between miR‑5580‑3p and LAMC2 mRNA. The results demonstrated that miR‑5580‑3p expression was downregulated, while LAMC2 expression was upregulated in OC tissues and cell lines. In addition to the observation that miR‑5580‑3p promoted the malignant phenotypes of OC, it was also revealed that miR‑5580‑3p inhibited OC cell viability, proliferation and migration by suppressing LAMC2. Therefore, the present study suggested that miR‑5580‑3p and LAMC2 may be potential biomarkers and therapeutic targets for OC diagnosis and therapies in the future.
Insights
MicroRNA‑5580‑3p inhibits oral cancer progression by suppressing LAMC2. This microRNA and LAMC2 show potential as diagnostic biomarkers and therapeutic targets for oral cancer.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Oral cancer (OC) is a significant global health concern.
- Understanding the molecular mechanisms driving OC progression is crucial for developing effective therapies.
- The role of microRNAs and their interactions with target genes in OC remains an active area of research.
Purpose of the Study:
- To investigate the regulatory role of microRNA‑5580‑3p (miR‑5580‑3p) in oral cancer (OC) cell phenotypes.
- To identify and characterize the interaction between miR‑5580‑3p and laminin subunit γ2 (LAMC2) in OC.
- To explore the potential of miR‑5580‑3p and LAMC2 as biomarkers and therapeutic targets for OC.
Main Methods:
- Bioinformatics analysis to predict the miR‑5580‑3p/LAMC2 interactome.
- Reverse transcription-quantitative PCR (RT-qPCR) to assess miR‑5580‑3p and LAMC2 expression.
- Western blotting to determine LAMC2 protein levels.
- Cell proliferation (Cell Counting Kit-8, 5-bromo-2'-deoxyuridine) and migration (wound healing) assays.
- Luciferase reporter assays to confirm the interaction between miR‑5580‑3p and LAMC2 mRNA.
Main Results:
- miR‑5580‑3p expression was found to be downregulated in OC tissues and cell lines.
- LAMC2 expression was significantly upregulated in OC tissues and cell lines.
- miR‑5580‑3p inhibited OC cell viability, proliferation, and migration.
- This inhibition was mediated by the suppression of LAMC2 expression by miR‑5580‑3p.
Conclusions:
- miR‑5580‑3p plays a suppressive role in oral cancer progression.
- The miR‑5580‑3p/LAMC2 axis is a novel molecular pathway implicated in OC.
- miR‑5580‑3p and LAMC2 represent promising biomarkers and therapeutic targets for oral cancer diagnosis and treatment.
Related Concept Videos
Abnormal Proliferation
Hedgehog Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs

